You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial
|
---|---|
Published in |
Critical Care, May 2009
|
DOI | 10.1186/cc7890 |
Pubmed ID | |
Authors |
Michael C Reade, Kim O'Sullivan, Samantha Bates, Donna Goldsmith, William RSTJ Ainslie, Rinaldo Bellomo |
Abstract |
Agitated delirium is common in patients undergoing mechanical ventilation, and is often treated with haloperidol despite concerns about safety and efficacy. Use of conventional sedatives to control agitation can preclude extubation. Dexmedetomidine, a novel sedative and anxiolytic agent, may have particular utility in these patients. We sought to compare the efficacy of haloperidol and dexmedetomidine in facilitating extubation. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 80% |
United Kingdom | 1 | 20% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 2 | 40% |
Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Members of the public | 1 | 20% |
Science communicators (journalists, bloggers, editors) | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 303 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 1% |
Brazil | 3 | <1% |
United Kingdom | 2 | <1% |
Colombia | 2 | <1% |
Denmark | 2 | <1% |
Japan | 2 | <1% |
Canada | 1 | <1% |
Spain | 1 | <1% |
Unknown | 286 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 46 | 15% |
Researcher | 40 | 13% |
Student > Master | 38 | 13% |
Student > Postgraduate | 35 | 12% |
Professor > Associate Professor | 28 | 9% |
Other | 79 | 26% |
Unknown | 37 | 12% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 202 | 67% |
Nursing and Health Professions | 12 | 4% |
Agricultural and Biological Sciences | 10 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 9 | 3% |
Neuroscience | 5 | 2% |
Other | 16 | 5% |
Unknown | 49 | 16% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 April 2022.
All research outputs
#3,696,280
of 25,371,288 outputs
Outputs from Critical Care
#2,827
of 6,554 outputs
Outputs of similar age
#12,987
of 107,171 outputs
Outputs of similar age from Critical Care
#7
of 31 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,554 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.8. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 107,171 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.